These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disorders of hemostasis in overt and subclinical hypercortisolism. Świątkowska-Stodulska R; Sworczak K Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):588-94. PubMed ID: 24277483 [TBL] [Abstract][Full Text] [Related]
3. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis. Krysiak R; Okopien B Thromb Haemost; 2012 Nov; 108(5):973-80. PubMed ID: 22918596 [TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of disturbances of the hemostatic system in neonates]. Zhdanovych OI Lik Sprava; 2001; (2):86-8. PubMed ID: 11519441 [TBL] [Abstract][Full Text] [Related]
5. [Hemostatic disorders in liver disease]. Mitrică D; Drug VL; Prelipcean CC; Stan M Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):313-20. PubMed ID: 19294997 [TBL] [Abstract][Full Text] [Related]
6. Current use of biologicals in thrombosis and haemostasis. Ofosu FA; Barrowcliffe TW Thromb Haemost; 2008 May; 99(5):805-6. PubMed ID: 18449409 [No Abstract] [Full Text] [Related]
7. [Endotoxin aggression in the development of hemostatic disorders in children with surgical diseases]. Meshkov MV; Anikhovskaia IA; Urazaev RA; Iakovlev MIu Khirurgiia (Mosk); 2006; (3):32-7. PubMed ID: 16710238 [TBL] [Abstract][Full Text] [Related]
9. [Specificities of neonatal hemostasis and implications in pathologic situations]. Gruel Y Arch Pediatr; 2010 Sep; 17 Suppl 3():S93-100. PubMed ID: 20728815 [TBL] [Abstract][Full Text] [Related]
10. [Hemostatic disorders: clinical management based on molecular mechanisms]. Scharf RE Fortschr Neurol Psychiatr; 2011 Mar; 79(3):171-85; quiz 186-8. PubMed ID: 21394708 [No Abstract] [Full Text] [Related]
11. Coagulation testing in pediatric patients: the young are not just miniature adults. Lippi G; Franchini M; Montagnana M; Guidi GC Semin Thromb Hemost; 2007 Nov; 33(8):816-20. PubMed ID: 18175287 [TBL] [Abstract][Full Text] [Related]
12. Hemostatic disorders in type 1 diabetes mellitus. Targher G; Chonchol M; Zoppini G; Franchini M Semin Thromb Hemost; 2011 Feb; 37(1):58-65. PubMed ID: 21249604 [TBL] [Abstract][Full Text] [Related]
13. [Hemostasis disorders in severe infections: State of the art]. Fourrier F Med Mal Infect; 2006 Oct; 36(10):524-533. PubMed ID: 17191328 [TBL] [Abstract][Full Text] [Related]
14. [Problems of haemostasis and coagulation]. Darnige L; Fischer AM Rev Prat; 2013 May; 63(5):699-708. PubMed ID: 23789502 [No Abstract] [Full Text] [Related]
15. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. Malloy PC; Grassi CJ; Kundu S; Gervais DA; Miller DL; Osnis RB; Postoak DW; Rajan DK; Sacks D; Schwartzberg MS; Zuckerman DA; Cardella JF; J Vasc Interv Radiol; 2009 Jul; 20(7 Suppl):S240-9. PubMed ID: 19394868 [No Abstract] [Full Text] [Related]
17. Hemostatic and fibrinolytic abnormalities in polycystic ovary syndrome. Targher G; Zoppini G; Bonora E; Moghetti P Semin Thromb Hemost; 2014 Jul; 40(5):600-18. PubMed ID: 25000958 [TBL] [Abstract][Full Text] [Related]
18. [Endotoxin aggression as a universal factor of pathogenesis of hemostatic disorders in children with urological pathology]. Meshkov MV; Anikhovskaia IA; Gataullin IuK; Iakovlev MIu Urologiia; 2006; (1):15-9. PubMed ID: 16550816 [TBL] [Abstract][Full Text] [Related]